Publications | Lund University Publications

1 – 10 of 71

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%220732-183X%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
7
8
next »

2025
Mark Pancreatic Adenocarcinoma : Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Palmer, Daniel H. ; Jackson, Richard ; Springfeld, Christoph ; Ghaneh, Paula ; Rawcliffe, Charlotte ; Halloran, Christopher M. ; Faluyi, Olusola ; Cunningham, David ; Wadsley, Jonathan and Darby, Suzanne , et al. (2025) In Journal of Clinical Oncology 43(10). p.1240-1253
- Contribution to journal › Article
Mark Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer : Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group
Kooijmans, Esmee C.M. ; Mulder, Renée L. ; Marks, Stephen D. ; Pavasovic, Vesna ; Motwani, Shveta S. ; Walwyn, Thomas ; Larkins, Nicholas G. ; Kruseova, Jarmila ; Constine, Louis S. and Hamish Wallace, W. , et al. (2025) In Journal of Clinical Oncology 43(21). p.2433-2448
- Contribution to journal › Article
2024
Mark Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
Tobiasson, Magnus ; Pandzic, Tatjana ; Illman, Johanna ; Nilsson, Lars ; Weström, Simone ; Ejerblad, Elisabeth ; Olesen, Gitte ; Björklund, Andreas ; Kittang, Astrid Olsnes and Werlenius, Olle , et al. (2024) In Journal of Clinical Oncology 42(12). p.1378-1390
- Contribution to journal › Article
Mark Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Martelli, M. ; Jerkeman, M. ^LU and Zucca, Emanuele (2024) In Journal of Clinical Oncology 42(34). p.4071-4083
- Contribution to journal › Article
Mark Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
Matikas, A. ; Malmström, P. ^LU and Bergh, Jonas (2024) In Journal of Clinical Oncology 42(26). p.3077-3082
- Contribution to journal › Article
Mark Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors : A PanCareSurFup Study
Heymer, Emma J. ; Jóźwiak, Katarzyna ; Kremer, Leontien C. ; Winter, David L. ; de Vathaire, Florent ; Sunguc, Ceren ; Sugden, Elaine ; Kok, Judith L. ; van der Pal, Helena J.H. and Hjorth, Lars ^LU , et al. (2024) In Journal of Clinical Oncology 42(3). p.336-347
- Contribution to journal › Article
2023
Mark Risk Factors for Heart Failure among Pan-European Childhood Cancer Survivors : A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
De Baat, Esmée C. ; Feijen, Elizabeth A.M. ; Reulen, Raoul C. ; Allodji, Rodrigue S. ; Bagnasco, Francesca ; Bardi, Edit ; Belle, Fabiën N. ; Byrne, Julianne ; Van Dalen, Elvira C. and Debiche, Ghazi , et al. (2023) In Journal of Clinical Oncology 41(1). p.96-106
- Contribution to journal › Article
Mark Clonal Hematopoiesis and Risk of Incident Lung Cancer
Tian, Ruiyi ; Wiley, Brian ; Liu, Jie ; Zong, Xiaoyu ; Truong, Buu ; Zhao, Stephanie ; Uddin, Md Mesbah ; Niroula, Abhishek ^LU ; Miller, Christopher A. and Mukherjee, Semanti , et al. (2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(7). p.1423-1433
- Contribution to journal › Article
Mark Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
Sjöström, Martin ^LU ; Fyles, Anthony ; Liu, Fei Fei ; McCready, David ; Shi, Wei ; Rey-Mcintyre, Katrina ; Chang, S. Laura ; Feng, Felix Y. ; Speers, Corey W. and Pierce, Lori J. , et al. (2023) In Journal of Clinical Oncology 41(8). p.1533-1540
- Contribution to journal › Article
Mark Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
Arance, Ana ; De La Cruz-Merino, Luis ; Petrella, Teresa M. ; Jamal, Rahima ; Ny, Lars ; Carneiro, Ana ^LU ; Berrocal, Alfonso ; Márquez-Rodas, Ivan ; Spreafico, Anna and Atkinson, Victoria , et al. (2023) In Journal of Clinical Oncology 41(1). p.75-85
- Contribution to journal › Article

« previous
1
2
3
4
…
7
8
next »

your query:: Remove issn: 0732-183X